rhNGF

recombinant human nerve growth factor · Dompé Farmaceutici S.p.A

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for rhNGF, covering 2019-07-11 to 2020-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers [Phase 1]